N@N

Avisio, Inc.: Avisio, Inc. Signs Letter of Intent

^{Published on 2009-08-26 05:39:24 - Market Wire}
 

RIVERSIDE, CA--(Marketwire - August 26, 2009) - Avisio, Inc. (PINKSHEETS: [ AVIC ]), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.

The sensory technology will be incorporated into a highly sensitive handheld instrument designed for field testing, and can be used in agribusiness to help secure the safety and ongoing viability of the global food supply.

The same technology will allow doctors, nurses and humanitarian aid workers to instantly detect disease-causing pathogens, including West Nile Virus, dengue, malaria and encephalitis. The device will require no specialized training and can detect pathogens from human blood, urine and saliva samples.

Upon completion of the acquisition, Avisio intends to make the product commercially available in the second half of 2010.

For more information, please visit [ www.avisioinc.com ]

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Avisio Inc. Forward-looking statements are based largely on expectations and projections about future events and future trends and are subject to numerous assumptions, risks and uncertainties, which change over time. Avisio's actual results could differ materially from those anticipated in forward-looking statements and you should not place any undue reliance on such forward-looking statements.

The forward-looking statements in this news release are made as of the date hereof, and Avisio does not assume any obligation to update, amend or clarify them to reflect events, new information or circumstances occurring after the date hereof.